Angelo Limeta

808 total citations
9 papers, 410 citations indexed

About

Angelo Limeta is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Angelo Limeta has authored 9 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Surgery and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Angelo Limeta's work include Renal cell carcinoma treatment (3 papers), Bladder and Urothelial Cancer Treatments (3 papers) and CRISPR and Genetic Engineering (2 papers). Angelo Limeta is often cited by papers focused on Renal cell carcinoma treatment (3 papers), Bladder and Urothelial Cancer Treatments (3 papers) and CRISPR and Genetic Engineering (2 papers). Angelo Limeta collaborates with scholars based in Sweden, Denmark and Italy. Angelo Limeta's co-authors include Jens Nielsen, Francesco Gatto, Max Levin, Boyang Ji, Raphaël Ferreira, Johan Gustafsson, Pınar Kocabaş, Avlant Nilsson, Jonathan L. Robinson and Iván Domenzain and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Trends in biotechnology.

In The Last Decade

Angelo Limeta

8 papers receiving 407 citations

Peers

Angelo Limeta

MB

ONCOL

CR

IMMUN

BE

Diane Yang United States

Merve Çakır United States

Jose Roques United States

Shinyeong Ju South Korea

Anna Meyfour Iran

Xiaoyuan Jia China

Wojciech Senkowski Sweden

Su‐Jun Li China

Praful Aggarwal United States

Yaqi Gao China

Diane Yang United States

Angelo Limeta

384 ×1.2

MB

69 ×0.8

ONCOL

57 ×1.2

CR

40 ×1.1

IMMUN

14 ×0.5

BE

Citations per year, relative to Angelo Limeta Angelo Limeta (= 1×) peers Diane Yang

Countries citing papers authored by Angelo Limeta

Since Specialization

Citations

This map shows the geographic impact of Angelo Limeta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelo Limeta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelo Limeta more than expected).

Fields of papers citing papers by Angelo Limeta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelo Limeta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelo Limeta. The network helps show where Angelo Limeta may publish in the future.

Co-authorship network of co-authors of Angelo Limeta

This figure shows the co-authorship network connecting the top 25 collaborators of Angelo Limeta. A scholar is included among the top collaborators of Angelo Limeta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelo Limeta. Angelo Limeta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Limeta, Angelo, et al.. (2023). Targeted In Vivo Mutagenesis in Yeast Using CRISPR/Cas9 and Hyperactive Cytidine and Adenine Deaminases. ACS Synthetic Biology. 12(8). 2278–2289. 3 indexed citations

2.

Limeta, Angelo, Francesco Gatto, Markus J. Herrgård, Boyang Ji, & Jens Nielsen. (2023). Leveraging high-resolution omics data for predicting responses and adverse events to immune checkpoint inhibitors. Computational and Structural Biotechnology Journal. 21. 3912–3919. 4 indexed citations

3.

Gatto, Francesco, Siniša Bratulić, Eric Jonasch, et al.. (2023). Plasma and Urine Free Glycosaminoglycans as Monitoring and Predictive Biomarkers in Metastatic Renal Cell Carcinoma: A Prospective Cohort Study. JCO Precision Oncology. 7(7). e2200361–e2200361. 4 indexed citations

4.

Gatto, Francesco, Saeed Dabestani, Siniša Bratulić, et al.. (2022). Plasma and Urine Free Glycosaminoglycans as Monitoring Biomarkers in Nonmetastatic Renal Cell Carcinoma—A Prospective Cohort Study. European Urology Open Science. 42. 30–39. 10 indexed citations

5.

Bratulić, Siniša, Angelo Limeta, Francesca Maccari, et al.. (2022). Analysis of normal levels of free glycosaminoglycans in urine and plasma in adults. Journal of Biological Chemistry. 298(2). 101575–101575. 17 indexed citations

6.

Gatto, Francesco, Siniša Bratulić, Eric Jonasch, et al.. (2021). Plasma and urine free glycosaminoglycans as monitoring and predictive biomarkers in metastatic renal cell carcinoma: A prospective observational study.. Journal of Clinical Oncology. 39(15_suppl). e16540–e16540.

7.

Limeta, Angelo, Boyang Ji, Max Levin, Francesco Gatto, & Jens Nielsen. (2020). Meta-analysis of the gut microbiota in predicting response to cancer immunotherapy in metastatic melanoma. JCI Insight. 5(23). 106 indexed citations

8.

Robinson, Jonathan L., Pınar Kocabaş, Hao Wang, et al.. (2020). An atlas of human metabolism. Science Signaling. 13(624). 240 indexed citations

9.

Ferreira, Raphaël, Angelo Limeta, & Jens Nielsen. (2018). Tackling Cancer with Yeast-Based Technologies. Trends in biotechnology. 37(6). 592–603. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact